Skip to main content
All lobbying filings

AVIVA STRATEGIES (FKA MGB CONSULTING)

Lobbying for ULTRAGENYX PHARMACEUTICAL · Biopharma company

 Filing 1st Quarter - Termination
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
California
Representation ended
Jan 5, 2026
The registrant reported terminating its work for this client.

Official filing document

 Lobbying activity 1
Health Issues

n/a termination report

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem